Davidson, A. & Diamond, B. Autoimmune illnesses. N. Engl. J. Med. 345, 340–350 (2001).
Steinman, L. Immune remedy for autoimmune illnesses. Science 305, 212–216 (2004).
Maecker, H. T. et al. New instruments for classification and monitoring of autoimmune illnesses. Nat. Rev. Rheumatol. 8, 317–328 (2012).
Wahren-Herlenius, M. & Dörner, T. Immunopathogenic mechanisms of systemic autoimmune illness. Lancet 382, 819–831 (2013).
Tu, Z. et al. Design of therapeutic biomaterials to manage irritation. Nat. Rev. Mater. 7, 557–574 (2022).
Stearns, N. A., Lee, J., Leong, Ok. W., Sullenger, B. A. & Pisetsky, D. S. The inhibition of anti-DNA binding to DNA by nucleic acid binding polymers. PLoS ONE 7, e40862 (2012).
Jain, S. et al. Nucleic acid scavengers inhibit thrombosis with out growing bleeding. Proc. Natl Acad. Sci. USA 109, 12938–12943 (2012).
Holl, E. Ok. et al. The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contraction. Plast. Reconstr. Surg. 134, 420e–433e (2014).
Liu, F. et al. A cationic metal-organic framework to scavenge cell-free DNA for extreme sepsis administration. Nano Lett. 21, 2461–2469 (2021).
Liu, F. et al. Focusing on a number of mediators of sepsis utilizing multifunctional tannic acid-Zn2+-gentamicin nanoparticles. Matter 4, 3677–3695 (2021).
Huang, H. et al. Nanoparticulate cell-free DNA scavenger for treating inflammatory bone loss in periodontitis. Nat. Commun. 13, 5925 (2022).
Shi, C. et al. A nanoparticulate twin scavenger for focused remedy of inflammatory bowel illness. Sci. Adv. 8, eabj2372 (2022).
Solar, M. et al. Circulating cell-free DNAs as a biomarker and therapeutic goal for acetaminophen-induced liver harm. Adv. Sci. 10, 2206789 (2023).
Liang, H. et al. Cationic nanoparticle as an inhibitor of cell-free DNA-induced irritation. Nat. Commun. 9, 4291 (2018).
Peng, B. et al. Tuned cationic dendronized polymer: molecular scavenger for rheumatoid arthritis remedy. Angew. Chem. Int. Ed. 58, 4254–4258 (2019).
Wu, J. et al. Cationic block copolymer nanoparticles with tunable DNA affinity for treating rheumatoid arthritis. Adv. Funct. Mater. 30, 2000391 (2020).
Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487–496 (2007).
Yanai, H. et al. HMGB proteins perform as common sentinels for nucleic-acid-mediated innate immune responses. Nature 462, 99–103 (2009).
Li, Y., Berke, I. C. & Modis, Y. DNA binding to proteolytically activated TLR9 is sequence‐impartial and enhanced by DNA curvature. EMBO J. 31, 919–931 (2012).
Tug, S. et al. Correlation between cell free DNA ranges and medical analysis of illness development in systemic lupus erythematosus sufferers. Cell. Immunol. 292, 32–39 (2014).
Schmidt, N. W. et al. Liquid-crystalline ordering of antimicrobial peptide-DNA complexes controls TLR9 activation. Nat. Mater. 14, 696–700 (2015).
Holl, E. Ok. et al. Scavenging nucleic acid particles to fight autoimmunity and infectious illness. Proc. Natl Acad. Sci. USA 113, 9728–9733 (2016).
Lou, H. & Pickering, M. C. Extracellular DNA and autoimmune illnesses. Cell. Mol. Immunol. 15, 746–755 (2018).
Duvvuri, B. & Lood, C. Cell-free DNA as a biomarker in autoimmune rheumatic illnesses. Entrance. Immunol. 10, 502 (2019).
Lande, R. et al. CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α manufacturing in systemic sclerosis. Nat. Commun. 10, 1731 (2019).
Lee, E. Y., Lee, M. W. & Wong, G. C. L. Modulation of Toll-like receptor signaling by antimicrobial peptides. Semin. Cell Dev. Biol. 88, 173–184 (2019).
Herster, F. et al. Neutrophil extracellular trap-associated RNA and LL37 allow self-amplifying irritation in psoriasis. Nat. Commun. 11, 105 (2020).
Michailidou, D. et al. Immune complex-mediated neutrophil activation in sufferers with polymyalgia rheumatica. Rheumatology 62, 2880–2886 (2023).
Gilliet, M. & Lande, R. Antimicrobial peptides and self-DNA in autoimmune pores and skin irritation. Curr. Opin. Immunol. 20, 401–407 (2008).
Brooks, H., Lebleu, B. & Vivès, E. Tat peptide-mediated mobile supply: again to fundamentals. Adv. Drug Deliv. Rev. 57, 559–577 (2005).
Lee, E. Y. et al. A evaluate of immune amplification through ligand clustering by self-assembled liquid-crystalline DNA complexes. Adv. Colloid Interface Sci. 232, 17–24 (2016).
Lee, E. Y. et al. Helical antimicrobial peptides assemble into protofibril scaffolds that current ordered dsDNA to TLR9. Nat. Commun. 10, 1012 (2019).
Zielke, C., Nielsen, J. E., Lin, J. S. & Barron, A. E. Between good and evil: complexation of the human cathelicidin LL-37 with nucleic acids. Biophys. J. 123, 1316–1328 (2024).
Tursi, S. A. et al. Bacterial amyloid curli acts as a provider for DNA to elicit an autoimmune response through TLR2 and TLR9. PLoS Pathog. 13, e1006315 (2017).
Lee, E. Y. et al. Crystallinity of double-stranded RNA-antimicrobial peptide complexes modulates Toll-like receptor 3-mediated irritation. ACS Nano 11, 12145–12155 (2017).
Engelberg, Y. & Landau, M. The human LL-37(17-29) antimicrobial peptide reveals a practical supramolecular construction. Nat. Commun. 11, 3894 (2020).
Prell, J. S., O’Brien, J. T., Steill, J. D., Oomens, J. & Williams, E. R. Buildings of protonated dipeptides: the function of arginine in stabilizing salt bridges. J. Am. Chem. Soc. 131, 11442–11449 (2009).
Hao, L. T. et al. Sturdy, multifaceted guanidinium-based adhesion of bioorganic nanoparticles to moist organic tissue. JACS Au. 1, 1399–1411 (2021).
Prevette, L. E., Mullen, D. G. & Banaszak Holl, M. M. Polycation-induced cell membrane permeability doesn’t improve mobile uptake or expression effectivity of delivered DNA. Mol. Pharm. 7, 870–883 (2010).
Bernkop-Schnürch, A. Methods to beat the polycation dilemma in drug supply. Adv. Drug Deliv. Rev. 136–137, 62–72 (2018).
Guo, P. et al. Twin functionalized amino poly(glycerol methacrylate) with guanidine and Schiff-base linked imidazole for enhanced gene transfection and minimized cytotoxicity. J. Mater. Chem. B 3, 6911–6918 (2015).
Zheng, M. et al. ROS-responsive polymeric siRNA nanomedicine stabilized by triple interactions for the strong glioblastoma combinational RNAi remedy. Adv. Mater. 31, 1903277 (2019).
Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564–569 (2007).
Park, S. & Lippard, S. J. Redox state-dependent interplay of HMGB1 and cisplatin-modified DNA. Biochemistry 50, 2567–2574 (2011).
DeRouchey, J., Netz, R. R. & Rädler, J. O. Structural investigations of DNA-polycation complexes. Eur. Phys. J. E 16, 17–28 (2005).
Lee, J. et al. Nucleic acid-binding polymers as anti-inflammatory brokers. Proc. Natl Acad. Sci. USA 108, 14055–14060 (2011).
Klinman, D. M. Immunotherapeutic makes use of of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4, 249–259 (2004).
Zuniga, E. I., McGavern, D. B., Pruneda-Paz, J. L., Teng, C. & Oldstone, M. B. A. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus an infection. Nat. Immunol. 5, 1227–1234 (2004).
Trentham, D. E., Townes, A. S. & Kang, A. H. Autoimmunity to sort II collagen: an experimental mannequin of arthritis. J. Exp. Med. 146, 857–868 (1977).
Lee, S.-M. et al. Focused chemo-photothermal therapies of rheumatoid arthritis utilizing gold half-shell multifunctional nanoparticles. ACS Nano 7, 50–57 (2013).
Liu, X., Chen, S., Yan, Y., Liu, L. & Chen, Y. Nanoparticulate DNA scavenger loading methotrexate targets articular irritation to reinforce rheumatoid arthritis remedy. Biomaterials 286, 121594 (2022).
